In Regard to Nantavithya et al
To the Editor: We read the interesting results from a phase 2 randomized study comparing the toxicity and efficacy of stereotactic body proton therapy (SBPT) and stereotactic body radiation therapy (SBRT) for high-risk medically inoperable early-stage non-small cell lung cancer (NSCLC) by Nantavithya et al (1). Although their study was closed early because of poor accrual and insurance issues, a total of 19 patients receiving 50 Gy (relative biologic effectiveness) in 4 fractions were included for analysis.
Source: International Journal of Radiation Oncology * Biology * Physics - Category: Radiology Authors: Pervin Hurmuz, Gokhan Ozyigit Tags: Comment Source Type: research
More News: Biology | Cancer | Cancer & Oncology | Insurance | Lung Cancer | Non-Small Cell Lung Cancer | Physics | Proton Therapy | Radiation Therapy | Radiology | Study | Toxicology